SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000911916-15-000125
Filing Date
2015-05-05
Accepted
2015-05-05 17:08:44
Documents
2
Period of Report
2015-05-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1655
2 POWER OF ATTORNEY - MATTHEW D. DALLAS dallaspoa.htm EX-24 3124
  Complete submission text file 0000911916-15-000125.txt   6228
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 781-365-2596
CoLucid Pharmaceuticals, Inc. (Issuer) CIK: 0001348649 (see all company filings)

IRS No.: 203419541 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AVEO PHARMACEUTICALS, INC. 650 EAST KENDALL STREET CAMBRIDGE MA 02142
Business Address
Dallas Matthew D (Reporting) CIK: 0001612396 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37358 | Film No.: 15833961